December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th& 12th 2024
ONLINE MEETINGS
Home » Collaborative and Licensing Opportunity Presentations
The Collaborative and Licensing Opportunity Presentations are a great opportunity for TTOs, universities, research institutes and companies to showcase their early-stage technologies in front of potential partners in the Life Sciences field, in order to entail a collaborative project and/or a licensing deal.
The selected candidates will be offered to present and promote their assets in front of the BioFIT participants.
The winner will be recognised as the most promising early-stage technology in Europe in Life Sciences.
Before September 26th, 2024
To apply to the Collaborative and Licensing Opportunity Presentations you must be registered to BioFIT.
To apply, the candidate must:
Before the event
During BioFIT
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.